Does SGLT1 inhibition add to the benefits of SGLT2 inhibition in the prevention and treatment of heart failure?

Bertram Pitt
, Deepak L. Bhatt
, Marco Metra

Research output: Contribution to journal › Article › peer-review

35 Scopus citations

Original language	English
Pages (from-to)	4754-4757
Number of pages	4
Journal	European Heart Journal
Volume	43
Issue number	45
DOIs	https://doi.org/10.1093/eurheartj/ehac417
State	Published - 1 Dec 2022
Externally published	Yes

Access to Document

10.1093/eurheartj/ehac417

Cite this

@article{eead79e490494e03b025dc9cfeeb1f56,

title = "Does SGLT1 inhibition add to the benefits of SGLT2 inhibition in the prevention and treatment of heart failure?",

author = "Bertram Pitt and Bhatt, \{Deepak L.\} and Marco Metra",

year = "2022",

month = dec,

day = "1",

doi = "10.1093/eurheartj/ehac417",

language = "English",

volume = "43",

pages = "4754--4757",

journal = "European Heart Journal",

issn = "0195-668X",

publisher = "Oxford University Press",

number = "45",

}

TY - JOUR

T1 - Does SGLT1 inhibition add to the benefits of SGLT2 inhibition in the prevention and treatment of heart failure?

AU - Pitt, Bertram

AU - Bhatt, Deepak L.

AU - Metra, Marco

PY - 2022/12/1

Y1 - 2022/12/1

UR - https://www.scopus.com/pages/publications/85143180866

U2 - 10.1093/eurheartj/ehac417

DO - 10.1093/eurheartj/ehac417

M3 - Article

C2 - 35979811

AN - SCOPUS:85143180866

SN - 0195-668X

VL - 43

SP - 4754

EP - 4757

JO - European Heart Journal

JF - European Heart Journal

IS - 45

ER -